Serodiagnosis of Primary Infections with Human Parvovirus 4, Finland
Anne Lahtinen, Pia Kivelä, Lea Hedman, Arun Kumar, Anu Kantele, Maija Lappalainen, Kirsi Liitsola, Matti Ristola, Eric Delwart, Colin P. Sharp, Peter Simmonds, Maria Söderlund-Venermo, and Klaus Hedman
Author affiliations: Author affiliations: University of Helsinki, Helsinki, Finland (A. Lahtinen, L. Hedman, A. Kumar, A. Kantele, M. Söderlund-Venermo, K. Hedman); Helsinki University Central Hospital, Helsinki (P. Kivelä, L. Hedman, A. Kantele, M. Lappalainen, M. Ristola, K. Hedman); National Institute for Health and Welfare, Helsinki (K. Liitsola); Blood System Research Institute, San Francisco, California, USA (E. Delwart); University of California, San Francisco (E. Delwart); University of Edinburgh, Summerhall, UK (C. Sharp, P. Simmonds)
Main Article
Table 1
Virologic findings for PARV4 primary infections in 2 patients, Finland*
Patient |
Date of sampling |
IgG EIA absorbance |
IgM EIA absorbance |
PCR |
IgG avidity, % |
A
|
2004 Sep 8 |
0.016 |
0.051 |
– |
ND |
2006 Mar 14
|
2.873
|
0.218
|
+
|
17.7
|
B |
2006 Mar 13 |
0.950 |
1.461 |
+ |
8.9 |
2006 Apr 6 |
1.946 |
0.661 |
+ |
10.1 |
Main Article
Page created: July 08, 2011
Page updated: July 08, 2011
Page reviewed: July 08, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.